Saltar al contenido
Merck

Clinical practice: Adult attention deficit-hyperactivity disorder.

The New England journal of medicine (2013-11-15)
Nora D Volkow, James M Swanson
RESUMEN

Short-term trials involving adults with ADHD have shown significant improvements in symptoms with stimulants and atomoxetine; however, data on long-term benefits and risks of these medications, particularly among older persons, have been insufficient.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
(R)-Tomoxetine hydrochloride, solid